Atrial Fibrillation Patient Preference Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography.
- Status
- COMPLETED
- Phase
- N/A
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
- Status
- COMPLETED
- Phase
- N/A
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
- Status
- COMPLETED
- Phase
- PHASE2
Anticoagulation Preference by AF Patients Study
- Status
- COMPLETED
- Phase
- N/A
Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
- Status
- COMPLETED
- Phase
- N/A
Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- WITHDRAWN
- Phase
- PHASE2
To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
- Status
- COMPLETED
- Phase
- N/A
A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension
- Status
- COMPLETED
- Phase
- N/A
A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department
- Status
- COMPLETED
- Phase
- PHASE4
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
- Status
- COMPLETED
- Phase
- PHASE2
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
- Status
- COMPLETED
- Phase
- PHASE4
Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."
- Status
- COMPLETED
- Phase
- N/A
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1